Related Experiment Video
Updated: Jun 22, 2026
09:11
A Mouse Model of in Utero Transplantation
Published on: January 27, 2011
Fetal cell microchimerism in human cancers.
Laura Fugazzola1, Valentina Cirello, Paolo Beck-Peccoz
1Department of Medical Sciences, University of Milan and Endocrine Unit, Fondazione Policlinico IRCCS, Milan, Italy. l.fugazzola@policlinico.mi.it
Cancer Letters
|June 23, 2009
Summary
Fetal cells can persist in mothers long-term, a phenomenon called fetal cell microchimerism. Research is exploring its role in cancer development and tissue repair.
Area of Science:
- Reproductive immunology
- Cellular biology
- Oncology
Background:
- Fetal cells normally transfer to maternal circulation during pregnancy.
- Post-partum persistence of these cells, known as fetal cell microchimerism, is well-established.
- Long-term consequences of fetal cell microchimerism are still under investigation.
Purpose of the Study:
- To review the potential role of fetal cell microchimerism in carcinogenesis.
- To explore the differentiation capacity of fetal microchimeric cells in maternal tissues.
- To present findings from animal models and human cancer studies.
Main Methods:
- Literature review of studies on fetal cell microchimerism.
- Analysis of data from animal models.
- Examination of studies involving women with various cancers.
Main Results:
- Fetal cell microchimerism is a demonstrated phenomenon with potential long-term health implications.
- The involvement of microchimerism in cancer development is an active area of research.
- Fetal cell differentiation and participation in maternal tissue repair are under investigation.
Conclusions:
- Fetal cell microchimerism warrants further study to understand its full impact on maternal health.
- Investigating microchimerism may offer new insights into cancer pathogenesis and regenerative processes.
- This review synthesizes current knowledge on fetal cell microchimerism and its consequences.
